Literature DB >> 29192764

Light Control of Protein Solubility Through Isoelectric Point Modulation.

Karthik Nadendla1, Simon H Friedman1.   

Abstract

We previously described the photoactivated depot or PAD approach that allows for the light control of therapeutic protein release. This approach relies on the ability to use light to change a protein's solubility. Traditionally this was accomplished by linking the protein to an insoluble but injectable polymer via a light cleaved linker. This allows the injected material to remain at the site of injection, until transcutaneous irradiation breaks the link between polymer and protein, permitting the protein to be absorbed. However, there are multiple problems associated with polymer based approaches: The polymer makes up a majority of the material, making it inefficient. In addition, after protein release, the polymer has to be cleared from the body, a significant design challenge. In this work, we create materials that form photoactivated depots of insulin without the need for polymers, by linking photolysis to an isoelectric point shift, which itself is linked to a solubility shift. Specifically, we linked basic groups to insulin via a light cleaved linker. These shift the normal pI of insulin from 5.4 to approximately 7. The result of this incorporation are materials that are completely soluble in mildly acidic solutions but precipitate upon injection into a pH 7 environment, i.e., the skin. We successfully synthesized four such modified insulins, demonstrating that their pI values were shifted in the expected manner. We then analyzed one of them, P2-insulin, in detail, demonstrating that it behaves as designed: It is soluble in a formulation pH of 4, but precipitates at pH 7.2, its approximate pI value. Upon irradiation, the photocleavable link to insulin is broken, and completely native and soluble insulin is released from the depot in a well behaved, first order fashion. These materials are 90% therapeutic, form completely soluble and injectable formulations in mildly acidic conditions, form insoluble depots at neutral pH, efficiently release soluble protein from these depots when irradiated, and leave behind only small easily absorbed molecules after irradiation. As such they approach ideality for photoactivated depot materials.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29192764      PMCID: PMC6362458          DOI: 10.1021/jacs.7b08465

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  36 in total

1.  Whole proteome pI values correlate with subcellular localizations of proteins for organisms within the three domains of life.

Authors:  R Schwartz; C S Ting; J King
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Authors:  H Yki-Järvinen; A Dressler; M Ziemen
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

3.  Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

Authors:  L Heinemann; R Linkeschova; K Rave; B Hompesch; M Sedlak; T Heise
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

4.  Light-activated RNA interference.

Authors:  Samit Shah; Subhashree Rangarajan; Simon H Friedman
Journal:  Angew Chem Int Ed Engl       Date:  2005-02-18       Impact factor: 15.336

5.  Subcellular pH and predicted pH-dependent features of proteins.

Authors:  Pedro Chan; Josip Lovrić; Jim Warwicker
Journal:  Proteomics       Date:  2006-06       Impact factor: 3.984

6.  Insulin analogues with increased mitogenic potency--are they safe?

Authors:  B F Hansen
Journal:  Horm Metab Res       Date:  2008-04-16       Impact factor: 2.936

7.  Insulin glargine.

Authors:  P S Gillies; D P Figgitt; H M Lamb
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

8.  Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Authors:  M Lepore; S Pampanelli; C Fanelli; F Porcellati; L Bartocci; A Di Vincenzo; C Cordoni; E Costa; P Brunetti; G B Bolli
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

9.  Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

Authors:  P Kurtzhals; L Schäffer; A Sørensen; C Kristensen; I Jonassen; C Schmid; T Trüb
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

10.  A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Authors:  Elizabeth A Doyle; Stuart A Weinzimer; Amy T Steffen; Jo Ann H Ahern; Miranda Vincent; William V Tamborlane
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

View more
  8 in total

1.  Hydrophobic Tags for Highly Efficient Light-Activated Protein Release.

Authors:  Karthik Nadendla; Bhagyesh R Sarode; Simon H Friedman
Journal:  Mol Pharm       Date:  2019-05-31       Impact factor: 4.939

Review 2.  Replacing Pumps with Light Controlled Insulin Delivery.

Authors:  Simon H Friedman
Journal:  Curr Diab Rep       Date:  2019-11-06       Impact factor: 4.810

3.  Visible-Light-Activated High-Density Materials for Controlled in Vivo Insulin Release.

Authors:  Bhagyesh R Sarode; Karen Kover; Simon H Friedman
Journal:  Mol Pharm       Date:  2019-10-24       Impact factor: 4.939

Review 4.  Protein Design: From the Aspect of Water Solubility and Stability.

Authors:  Rui Qing; Shilei Hao; Eva Smorodina; David Jin; Arthur Zalevsky; Shuguang Zhang
Journal:  Chem Rev       Date:  2022-08-03       Impact factor: 72.087

5.  The Issue of Tissue: Approaches and Challenges to the Light Control of Drug Activity: A Mini-Review.

Authors:  Mayank Sharma; Simon H Friedman
Journal:  ChemPhotoChem       Date:  2021-03-10

6.  Chemical modification of proteins with photocleavable groups.

Authors:  Karthik Nadendla; Bhagyesh Sarode; Simon H Friedman
Journal:  Methods Enzymol       Date:  2019-04-25       Impact factor: 1.600

7.  A Light Activated Glucagon Trimer with Resistance to Fibrillation.

Authors:  Swetha Chintala; Simon H Friedman
Journal:  ACS Biomater Sci Eng       Date:  2021-03-11

8.  Contribution to the Understanding of the Interaction between a Polydopamine Molecular Imprint and a Protein Model: Ionic Strength and pH Effect Investigation.

Authors:  Amal Tlili; Ghada Attia; Sohayb Khaoulani; Zouhour Mazouz; Chouki Zerrouki; Nourdin Yaakoubi; Ali Othmane; Najla Fourati
Journal:  Sensors (Basel)       Date:  2021-01-17       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.